Pfizer Inc. has secured an exclusive global licensing agreement with 3SBio, Inc., a leading Chinese biopharma, for SSGJ-707.

Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

The FDA has granted approval to GSK's Nucala as an add-on maintenance treatment for adult patients suffering from inadequately controlled COPD.

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

Sanofi has entered into an agreement to acquire Vigil Neuroscience Inc., a publicly traded clinical-stage biotechnology ...

Waters Corp. has acquired Halo Labs, a company specialized in imaging technologies to detect, identify, and count interfering ...

Inhaled therapeutics is an area of the pharmaceutical industry that is in high demand and is set for continued growth in the ...

The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...

There have been a growing number of drug products approved that look to target the brain following intranasal delivery.

Oral solid dosage forms such as tablets and capsules remain the most widely used method for delivering drug products to ...

Pharmaceutical granulation techniques continue to be developed and improved with modified / novel technologies and processing ...